InsidersTradesSigma
Follow the Vitrolife AB share price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Vitrolife AB has published 3 insider filings. Market capitalisation: €11.9bn. The latest transaction was reported on 6 February 2026 (Purchase). Among the most active insiders: Bronwyn Brophy O'Connor. The full history is openly available.
3
Insider Decl.
n/a
Thresholds
€98,038
3 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Vitrolife AB Strong Buy (bullish), based on 5 analysts. Average price target: SEK 129.60.
36Σ signal
Fundamental score
Ranked 21,104 of 29,063 companies
36.5
score / 100
Value32
Quality41
FCF yld3.1%
Earn yld-40%
EV/EBITDA·
ROE-47%
Gross mgn58%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 February 2026
Declarations3 total
3,013 shares@ €8.38450.0002% mcap100.0% of flowAktieISIN SE0011205202FI:A003V712-1
6,470 shares@ €8.35920.0004% mcap100.0% of flowAktieISIN SE0011205202FI:A003V709-1
2,200 shares@ €8.49610.0001% mcap100.0% of flowAktieISIN SE0011205202FI:A003V642-1
3 of 3 declarations
Acerca de Vitrolife AB
Vitrolife AB es una empresa del sector sanitario y farmacéutico, que ofrece soluciones para la fertilidad y el desarrollo embrionario. Cotiza en la bolsa XSTO.